Back
Protagonist Therapeutics Quote, Financials, Valuation and Earnings
Gold Set to Skyrocket as Fed Slashes Rates
Click here for the details on this incredible opportunity.
Buy
51
PTGX
Protagonist Therapeutics
Last Price:
46.48
Seasonality Move:
13.32%
7 Day Trial
ALL ACCESS PASS
$
7
The truth about AI stocks (must see)
Learn the names of all 10 stocks here. FREE.Protagonist Therapeutics Price Quote
$46.48
+0.04 (+1.13%)
(Updated: October 23, 2024 at 6:17 AM ET)
Protagonist Therapeutics Key Stats
Buy
51
Protagonist Therapeutics (PTGX)
is a Buy
Day range:
$45.33 - $46.53
52-week range:
$13.72 - $48.32
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
5.05%
Volume:
310.1K
Avg. volume:
667K
1-year change:
222.05%
Market cap:
$2.7B
Revenue:
$60M
EPS:
$2.62
How Much Does Protagonist Therapeutics Make?
Data Unavailable
Is Protagonist Therapeutics Growing As A Company?
Data Unavailable
Protagonist Therapeutics Stock Price Performance
-
Did Protagonist Therapeutics Stock Go Up Last Month?
Protagonist Therapeutics share price went down by -1.88% last month -
Did PTGX's Share Price Rise Over The Last Year?
PTGX share price rose by 222.05% over the past 1 year
What Is Protagonist Therapeutics 52-Week High & Low?
-
What Is Protagonist Therapeutics’s 52-Week High Share Price?
Protagonist Therapeutics has traded as high as $48.32 over the past 52 weeks -
What Is Protagonist Therapeutics’s 52-Week Low Share Price?
Protagonist Therapeutics has traded as low as $13.72 over the past 52 weeks
Protagonist Therapeutics Price To Free Cash Flow
-
Is Protagonist Therapeutics Stock Overvalued?
Protagonist Therapeutics is trading at a price to free cash flow ratio of 12.30 -
Is Protagonist Therapeutics Stock Undervalued?
Protagonist Therapeutics EV to Free Cash Flow ratio is 9.41 -
What Is Protagonist Therapeutics’s Price Earnings Growth Ratio?
PTGX PEG ratio is 0.00 -
Is Protagonist Therapeutics Trading At A Premium To Earnings?
Protagonist Therapeutics EV to EBIT ratio is 14.26
Is It Risky To Buy Protagonist Therapeutics?
-
How Much Debt Does Protagonist Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Protagonist Therapeutics Have?
Cash and short term investments quarterly total is $564M -
What Is Protagonist Therapeutics’s Book Value Per Share?
Book value per share is 9.21
Is Protagonist Therapeutics Cash Flow Positive?
-
What Is PTGX Cash Flow From Operations?
Cash flow from operations (TTM) is $231.5M -
What Is Protagonist Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $45.6M -
What Is Protagonist Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$156.9M
Protagonist Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
PTGX return on invested capital is 41.77% -
What Is Protagonist Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is 37.73% -
What Is PTGX Return On Equity?
ROE is a measure of profitability and is 41.77%
Protagonist Therapeutics Earnings Date & Stock Price
-
What Is Protagonist Therapeutics's Stock Price Today?
A single share of PTGX can be purchased today for 46.44 -
What Is Protagonist Therapeutics’s Stock Symbol?
Protagonist Therapeutics trades on the nasdaq under the ticker symbol: PTGX -
When Is Protagonist Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Protagonist Therapeutics is scheduled on November 1, 2024 -
When Is PTGX's next ex-dividend date?
Protagonist Therapeutics's next ex-dividend date is October 23, 2024 -
How To Buy Protagonist Therapeutics Stock?
You can buy Protagonist Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Protagonist Therapeutics Competitors
-
Who Are Protagonist Therapeutics's Competitors?
Below is a list of companies who compete with Protagonist Therapeutics or are related in some way:
Protagonist Therapeutics Dividend Yield
-
What Is PTGX Dividend Yield?
Protagonist Therapeutics’s dividend yield currently is 0% -
What Is Protagonist Therapeutics’s Payout Ratio?
Protagonist Therapeutics’s payout ratio is 0% -
When Did Protagonist Therapeutics Last Pay A Dividend?
The latest dividend pay date is October 23, 2024 -
What Is Protagonist Therapeutics’s Dividend Per Share?
Protagonist Therapeutics pays a dividend of $0.00 per share
Protagonist Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | -21.11% |
| Revenue: | 0% | -37.5% |
Analyst Recommendations
| Buy Recommendations: | 5 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 52.13 |
| Upside from Last Price: | 12.24% |